To be able to say which tumors are likely to progress and become problematic vs. those that are much more indolent or slow-growing would be very helpful in allowing a patient to make a very important decision: whether he wants active treatment or not.

263

Testing by any of the available recommended methods is a reasonable choice. The only unreasonable choice is not to be tested.

248

Rates of colorectal cancer screening should be as good as or better than mammography rates if the nation really wants to gain the greatest level of benefit from both a prevention and early detection standpoint.

207

The fact is, African Americans have not benefited equally from the improvements that are making a difference.

172